Digital engagement platform
Search documents
ON24 (ONTF) Q3 Earnings Report Preview: What To Look For
Yahoo Finance· 2025-11-09 03:02
Core Insights - ON24 is set to report earnings after market hours, with analysts expecting a revenue decline of 6.8% year on year to $33.85 million, consistent with a 7.4% decrease from the same quarter last year [2] - The company previously reported revenues of $35.33 million, down 5.4% year on year, but beat analysts' revenue expectations by 1.9% [1] - ON24 has a history of exceeding Wall Street's expectations, beating revenue estimates by an average of 2.8% over the past two years [3] Revenue and Earnings Expectations - Analysts expect adjusted earnings to be $0.01 per share for the upcoming quarter [2] - The average analyst price target for ON24 is $5, while the current share price is $4.94, indicating a slight potential upside [5] Peer Performance - In the sales and marketing software segment, AppLovin reported year-on-year revenue growth of 17.3%, beating expectations by 4.5%, while Integral Ad Science saw a revenue increase of 15.6%, exceeding estimates by 3.4% [4] - ON24's share price has decreased by 7.3% over the past month, contrasting with the stable performance of its peers [5]
New Strong Sell Stocks for Oct. 31st
ZACKS· 2025-10-31 09:36
Group 1: Company Performance - 1-800-FLOWERS.COM (FLWS) is a leading e-commerce provider of floral products and gifts, with a significant customer base and revenue. The Zacks Consensus Estimate for its current year earnings has been revised downward by almost 87.9% over the last 60 days [1] - Bridgeline Digital (BLIN) is a digital engagement company that offers a platform integrating Web Content Management, e-commerce, e-marketing, Social Media management, and Web Analytics. The Zacks Consensus Estimate for its current year earnings has been revised downward by almost 12% over the last 60 days [2] - Avita Medical (RCEL) is a regenerative medicine company focused on developing and commercializing a technology platform for point-of-care autologous skin restoration. The Zacks Consensus Estimate for its current year earnings has been revised downward by 6.5% over the last 60 days [3] Group 2: Market Sentiment - All three companies have been added to the Zacks Rank 5 (Strong Sell) List, indicating a negative market sentiment towards their current performance and future earnings potential [1][2][3]